CNDSNAugust 14th] (first financial daily) recently, the health information released online pharmacies drug market in 2014 market statistics, which show that online pharmacies its drug sales accounted for only 22.8% of the drug sales, medical equipment sales contribution is ranked first, occupy 25.8% of the total. This is a sharp contrast to the traditional line of pharmacy sales pattern, which is still dominated by drug sales, drug contribution rate accounted for 46.6%. 2014 online pharmacies category sales structure

Online based line

1 instruments: 25.8% drugs: 46.6%

2 drugs: 22.8% instruments: 20.9%

3 contact lenses: 17% health products: 12.4%

4 health products: 14.3% health care products: 6.9%

5 daily necessities: 13.3% daily necessities: 5.7%

6 health care products: 3% contact lenses: 4.6%

Online and offline based online pharmacies in the category of sales structure has obvious differences, online based drug store category shows a diversified trend, drug sales are no longer dominated, and equipment, health daily necessities to show the average pattern; and the line is significant to the drug store, the contribution rate is close to two, medical equipment category accounted for 50%.

The report also pointed out that in 2014 the overall size of China's online pharmacies sales reached 7200000000 yuan, an increase of 71.4% in 2013, the number of national food and drug administration system registration online pharmacies in the number 2014, and as of June 2015, the number has increased to 315, online pharmacies in high speed growth stage.

Obviously, for the net of the pharmacy, functions are no longer as the sell drugs, health products including medical equipment, daily necessities, appliances, health surrounding became profitable with the mainstream. And in fact, not just online pharmacies, for the traditional pharmaceutical companies, the main business is subject to the health care costs, pharmaceutical tender reform and other multiple reasons, profitability has declined, and health products, but in the sales revenue has ushered in the growth rate is much higher than the growth rate of drugs.

According to the Yunnan Baiyao (000538. SZ) announced the 2014 earnings, the pharmaceutical division throughout the year total revenue for 49.7 billion yuan, an increase of 12.58%, and health products division of total revenue for 27.5 billion yuan, an increase of has reached 32.66%.

"In fact Yunnanbaiyao health products the main is to rely on the toothpaste a big category in the money, the toothpaste category of income over the income of many drugs, so you can imagine the develop a healthy surrounding the fist products for the pharmaceutical enterprises affect how much the." An industry source told reporters.

In selling products, Yunnan Baiyao main hemostatic effect and high quality, each of the toothpaste priced at 20 yuan, when Yunnan Baiyao concept is: we only 10 million people doing toothpaste. Such as the 1000 million on behalf of 1000 million family, each family an annual consumption of 8 Yunnanbaiyao toothpaste, a year totals can sell 8000 million toothpaste. Even taking into account the individual consumers will be regular or irregular replacement of toothpaste brands, the market capacity is considerable.

And for pharmacies, a 4 yuan of toothpaste, the general retail store to earn 15% gross profit margin is 0.6 yuan, but if it is a 15% yuan of 20 yuan of gross profit margin of 3 yuan, health products far more than ordinary day.

Can be observed a phenomenon is that not only is the Yunnan Baiyao, most pharmaceutical enterprises including Pien Tze Huang (600436.SH), Shanghai Pharmaceutical (601607.SH), Zhendong Pharmaceutical (300158.SZ) are in seek to the transformation of the "health", which cosmetic, maternal and child products become first choice.

"Mass consumption is increasingly favored natural raw materials. Therefore, plant type or 'medicine' concept of products, I believe in Xihu areas will become more and more popular. As a subsidiary of Zhendong group, we will with pharmaceutical advantage to develop, including maternal and child products, cosmetics and washing products, the future will be the focus of development of the company, in the sales channels will focus on network channels. " Zhendong group, a subsidiary of Zhendong home guard, chairman of Lu Zirui previously when accepting a reporter to interview said, "the next 10 years, the Chinese infant toiletries market size will exceed 300 billion, we hope from cutting a block belongs to traditional Chinese medicine toiletries market." 3

(original title: online pharmacy sales diversified chemical pharmaceutical companies earn more than drugs)

Editor: small G